Yemeni Minister: $28 Billion Needed for Short-Term Reconstruction Plans

Yemeni Minister of Planning and International Cooperation Najib al-Auj
Yemeni Minister of Planning and International Cooperation Najib al-Auj
TT

Yemeni Minister: $28 Billion Needed for Short-Term Reconstruction Plans

Yemeni Minister of Planning and International Cooperation Najib al-Auj
Yemeni Minister of Planning and International Cooperation Najib al-Auj

Yemen's Minister of Planning and International Cooperation, Najib al-Auj, said that the war-torn country needs a baseline $28-billion-dollar fund for reconstruction efforts over the next four years.

In the long term, Yemen’s reconstruction could run a bill as large as $60 billion for post-war restoration of institutions, stability and security.

Revamping the country’s ailing health, education and power sectors and rehabilitating city infrastructure figure high on the government’s agenda, Auj told Asharq Al-Awsat, saying the state will work to fix the general budget deficit.

Yemen’s government, for the first time in four years, had announced the budget and had it ratified by the Yemeni parliament.

“The challenge is to implement the 2019 budget. Many projects have been faltering. And state institutions are affected by the war and need to be rebuilt,” Auj noted, explaining that tremendous efforts need to be poured to get the country’s security sector back on its feet and have reconstruction processes rebooted.

The minister also pointed out that government reconstruction data indicates that the country needs an estimated $28 billion in the short term and around $60 billion over the long term.

“So far there are no field surveys or precise studies that can give a certain figure-- but as a starting point, signs show a need for a minimum of $28 billion in the short term—which runs from two and four years. After that, Yemen will need a full-fledged reconstruction which could cost as much as $60 billion in the long term.”

As for restoring the war-torn country’s international ties, Auj said that he had met with representatives from 24 international bodies and states, among which were the EU, New Zealand and Canada.

“Today, there are more than 80 European organizations that have opened offices in the interim capital, Aden. Earlier talk with the EU for reopening its bureaus in Aden are ongoing. They are studying this request and they promised to deliver our messages to decision makers,” Auj revealed.

Giving details about his meeting with Western officials, Auj confirmed relaying the importance of supporting projects related to farmers and fishermen, which represent the largest segment of the Yemeni population.

Aiding Yemen’s agricultural and farming sectors will help create jobs and give public-private sector relations a badly needed boost.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.